Market Closed -
Japan Exchange
11:30:00 28/06/2024 am IST
5-day change
1st Jan Change
3,717
JPY
+0.24%
+2.23%
-13.78%
Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100
Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100
Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100
24/06
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on May 23, 2024.
24/05
CI
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on May 23, 2024, has closed with 2,400,000 shares, representing 3.17% for ¥8,901.6 million.
24/05
CI
Hisamitsu Pharmaceutical Co., Inc. announces an Equity Buyback for 2,400,000 shares, representing 3.17% for ¥8,901.6 million.
23/05
CI
Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan.
23/05
CI
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024
11/04
MT
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise
12/01
MT
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
11/01
CI
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024
11/01
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
26/12
CI
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.
25/12
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
05/12
CI
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales
09/23/09
MT
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023
06/23/06
CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
04/23/04
CI
Hisamitsu Pharmaceutical Attributable Profit More Than Doubles in Fiscal Q1; Shares Climb 11%
14/23/14
MT
Hisamitsu Pharmaceutical Co., Inc. announces an Equity Buyback for 2,000,000 shares, for ¥10,000 million.
13/23/13
CI
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
13/23/13
CI
Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending February 29, 2024
13/23/13
CI
Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan.
13/23/13
CI
Hisamitsu Pharmaceutical Affirms Final Dividend on Higher FY23 Profit, Revenue
14/23/14
MT
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Year 2023, Effective May 26, 2023
13/23/13
CI
Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending February 29, 2024
13/23/13
CI
Hisamitsu Pharmaceutical Co., Inc. Announces Special Dividend for the Fiscal Year 2023
13/23/13
CI
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Year Ending February 29, 2024
13/23/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
More about the company
Last Close Price
3,717
JPY
Average target price
3,950
JPY
Spread / Average Target
+6.27%
Consensus
1st Jan change
Capi.
-13.78% 1.69B +55.32% 819B -6.75% 351B +13.56% 329B +10.68% 298B +16.57% 242B +2.04% 225B +13.31% 217B +8.48% 168B -2.81% 158B
Other Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
HISAMITSU PHARMACEUTICAL CO., INC. 
